ArticleJournal of nephrology2024

Lessons for the clinical nephrologist: legacy effects of bevacizumab and ramucirumab lead to nephrotic syndrome due to renal-limited thrombotic microangiopathy with podocytopathy.

Takahide Iwasaki et al.PubMed ↗Publisher ↗

No numbers read from the abstract.